Item 5.07Submission of Matters to a Vote of Security Holders.

Principia Biopharma Inc. (the "Company") held its annual meeting of stockholders (the "Annual Meeting") on June 4, 2020. The stockholders considered two proposals, both of which are described in more detail in the Company's definitive proxy statement filed with the Securities and Exchange Commission on April 24, 2020. The matters voted upon at the Annual Meeting and the results of such voting are set forth below.

Proposal 1: Election of Class II Directors



                Nominee         Votes For  Votes Withheld Broker Non-Votes
        Dan Becker, M.D., Ph.D. 26,425,531   2,397,032       1,409,778
        Patrick Machado         24,338,184   4,484,379       1,409,778

The Company's stockholders elected each of the two nominees for director to serve until the 2023 annual meeting of stockholders and until their respective successors are duly elected and qualified.

Proposal 2: Ratification of Appointment of Ernst & Young as the Company's Independent Registered Public Accounting Firm



                       Votes For  Votes Against Abstentions
                       30,227,260      170         4,911

The Company's stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2020.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses